Laviat 10mg Lenalidomide Price USA | Ernest Oncology Indian Exporter

Laviat 10mg Capsule: Precision Immunomodulatory Therapy for Hematological Malignancies

Are you looking for a trusted Laviat 10 mg capsule exporter from India? Ernest Oncology, a dedicated vertical of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of high-efficacy oncology medications. We maintain a specialized cold chain and regulatory-compliant supply network to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that critical hematology treatments are delivered with pharmaceutical-grade precision.

Detailed Product Overview: What is Laviat 10mg?

Laviat 10mg is an advanced oral antineoplastic treatment containing the active ingredient Lenalidomide. It is a cornerstone of modern hematology, classified as an Immunomodulatory Imide (IMiD). Laviat is specifically engineered to treat cancers of the blood and bone marrow by modulating the body's immune response and directly inhibiting the proliferation of malignant cells.

The 10mg dosage is a vital therapeutic strength. It is frequently prescribed for:

• Maintenance Therapy: Following successful induction or stem cell transplantation.

• Dose Titration: Providing a balanced approach for elderly patients or those with specific renal profiles.

• Combination Regimens: Working synergistically with dexamethasone or monoclonal antibodies.

Primary Therapeutic Indications:

Laviat 10mg is clinically authorized for the management of:

• Multiple Myeloma (MM): For both newly diagnosed patients (as maintenance) and those with relapsed or refractory disease.

• Myelodysplastic Syndromes (MDS): Specifically the 5q deletion subtype characterized by transfusion-dependent anemia.

• Mantle Cell Lymphoma (MCL): In patients who have relapsed after prior therapies.

• Follicular Lymphoma (FL): Often used for patients who have not responded to initial treatments.

Mechanism of Action: The Science of Laviat:

Laviat 10mg utilizes a sophisticated "four-pillar" approach to combat cancer:

1. Immune Activation: It stimulates T-cells and Natural Killer (NK) cells, enhancing the body’s innate ability to recognize and destroy "foreign" cancer cells.

2. Tumor Cell Apoptosis: It binds to the cereblon protein, triggering a cascade that leads to programmed cell death (apoptosis) in malignant plasma cells.

3. Anti-Angiogenesis: It inhibits the growth of new blood vessels that feed the tumor, effectively cutting off the cancer’s nutrient supply.

4. Cytokine Inhibition: It blocks the production of pro-inflammatory cytokines like TNF-α and IL-6, which cancer cells use to survive and multiply.

Administration and Safety:

• Dosage: Must be taken exactly as prescribed, typically in a 21-day "on" and 7-day "off" cycle.

• Instruction: Swallow capsules whole at the same time daily. Do not break or chew.

• Critical Warning: Embryo-Fetal Toxicity. Laviat is structurally related to thalidomide and can cause severe birth defects. Strict adherence to pregnancy prevention programs (REMS) is mandatory for both men and women.

• Common Side Effects: Fatigue, decreased blood cell counts (neutropenia/thrombocytopenia), diarrhea, and muscle cramps.

Why Source Laviat 10 mg from Ernest Oncology?

• Direct Indian Export: As a leading exporter from India, we source directly from GMP-certified facilities, ensuring 100% product authenticity.

• B2B Bulk Expertise: We specialize in large-scale supply for international hospitals, clinics, and pharmaceutical wholesalers.

• Global Logistics Reach: Verified delivery routes to USA, UK, UAE, Australia, and South Africa. 

• Comprehensive Portfolio: Availability of all strengths (5 mg, 10 mg, 15 mg, 25 mg) to ensure uninterrupted patient treatment cycles.